Back to Companies
Unicycive Therapeutics, Inc.
UNCYNasdaqCIK: 0001766140
Unicycive Therapeutics, Inc. (UNCY) shows 14 recent insider filings from 7 insiders, with no open-market buying or selling. Gupta Shalabh K. (CEO, Director) is the most active by dollar volume, and the single largest transaction was $1.5M by Gupta Shalabh K.. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$1.8M
Purchases
$0
Sales
$0
Unique Insiders
7
Recent Insider Trades
14 loaded
| Jul 28 | UNCY Unicycive Therapeutics, Inc. | Laumas Sandeep | Director | Award | $0 |
| Jun 15 | UNCY Unicycive Therapeutics, Inc. | Townsend John | CFO | Award | $0 |
| Jul 28 | UNCY Unicycive Therapeutics, Inc. | Kenkare-Mitra Sara | Director | Award | $0 |
| Jun 15 | UNCY Unicycive Therapeutics, Inc. | Jermasek Douglas | EVP, Corporate Strategy | Award | $0 |
| Jun 15 | UNCY Unicycive Therapeutics, Inc. | Laumas Sandeep | Director | Award | $0 |
| Jun 15 | UNCY Unicycive Therapeutics, Inc. | Gupta Shalabh K. | CEO, Director | Award | $0 |
| May 18 | UNCY Unicycive Therapeutics, Inc. | Laumas Sandeep | Director | Award | $0 |
| Jun 15 | UNCY Unicycive Therapeutics, Inc. | Kenkare-Mitra Sara | Director | Award | $0 |
| Jun 15 | UNCY Unicycive Therapeutics, Inc. | Gupta Pramod | EVP, Pharmaceuticals and BD | Award | $0 |
| Aug 26 | UNCY Unicycive Therapeutics, Inc. | Aggarwal Gaurav | Director | Conversion | $15.7K |
| Jul 30 | UNCY Unicycive Therapeutics, Inc. | Kenkare-Mitra Sara | Director | Award | $99.9K |
| Jul 30 | UNCY Unicycive Therapeutics, Inc. | Laumas Sandeep | Director | Award | $99.9K |
| Jul 30 | UNCY Unicycive Therapeutics, Inc. | Gupta Shalabh K. | CEO, Director | Award | $1.5M |
| Jul 30 | UNCY Unicycive Therapeutics, Inc. | Aggarwal Gaurav | Director | Award | $99.9K |
14 filings